Mary Ann Liebert, Inc., publishers, has announced the fall 2015 launch of Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal. The journal claims to be the only journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids.
Launching in fall 2015, the Journal will be the premier open source for authoritative cannabis and cannabinoid research, discussion, and debate. The journal will publish under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation.
Cannabis and Cannabinoid Research will publish fully peer-reviewed, evidence-based original articles, review articles, and perspectives on cannabis, cannabinoids, and the endocannabinoid system. The journal will publish a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies.
An interdisciplinary community including pharmacologists and psychopharmacologists, toxicologists, biochemists, neurologists, psychiatrists, physicians, and other healthcare practitioners, addiction specialists, and regulators and policymakers are invited to participate in this new open access resource.
Cannabis and Cannabinoid Research will build a central forum and repository for peer-reviewed open access papers, as more high-quality research is needed to move the field forward.
